Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program
2013 ◽
Vol 60
(11)
◽
pp. 1860-1867
◽
Andrew C. Wood
◽
John M. Maris
◽
Richard Gorlick
◽
E. Anders Kolb
◽
Stephen T. Keir
◽
...
2011 ◽
Vol 58
(5)
◽
pp. 815-818
◽
E. Anders Kolb
◽
Richard Gorlick
◽
Stephen T. Keir
◽
John M. Maris
◽
Richard Lock
◽
...
2014 ◽
Vol 61
(10)
◽
pp. 1816-1821
◽
E. Anders Kolb
◽
Richard Gorlick
◽
Catherine A. Billups
◽
Thomas Hawthorne
◽
Raushan T. Kurmasheva
◽
...
2010 ◽
Vol 55
(7)
◽
pp. 1329-1337
◽
Hernan Carol
◽
Christopher L. Morton
◽
Richard Gorlick
◽
E. Anders Kolb
◽
Stephen T. Keir
◽
...
2011 ◽
Vol 59
(1)
◽
pp. 185-188
◽
Min H. Kang
◽
C. Patrick Reynolds
◽
Peter J. Houghton
◽
Denise Alexander
◽
Christopher L. Morton
◽
...
Raushan Kurmasheva
◽
Kat Cosmopoulos
◽
Melissa Sammons
◽
Edward Favours
◽
Jianwrong Wu
◽
...
2011 ◽
Vol 58
(2)
◽
pp. 191-199
◽
Peter J. Houghton
◽
Richard Gorlick
◽
E. Anders Kolb
◽
Richard Lock
◽
Hernan Carol
◽
...
2015 ◽
Vol 62
(11)
◽
pp. 1897-1905
◽
C. Patrick Reynolds
◽
Min H. Kang
◽
John M. Maris
◽
E. Anders Kolb
◽
Richard Gorlick
◽
...
2011 ◽
Vol 59
(4)
◽
pp. 749-752
◽
Vandana Batra
◽
John M. Maris
◽
Min H. Kang
◽
C. Patrick Reynolds
◽
Peter J. Houghton
◽
...
2013 ◽
Vol 61
(2)
◽
pp. 245-252
◽
Hernan Carol
◽
Richard Gorlick
◽
E. Anders Kolb
◽
Christopher L. Morton
◽
Donya Moradi Manesh
◽
...